Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries GeneDx Holdings Corp. - Class A Common Stock (NQ: WGS ) 35.30 -0.29 (-0.81%) Streaming Delayed Price Updated: 11:12 AM EDT, Aug 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about GeneDx Holdings Corp. - Class A Common Stock < Previous 1 2 3 4 5 Next > Stocks That Hit 52-Week Lows On Wednesday August 23, 2023 Wednesday's session saw 150 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday August 22, 2023 On Tuesday, 210 companies reached new 52-week lows. Via Benzinga Where GeneDx Hldgs Stands With Analysts August 09, 2023 Via Benzinga Recap: GeneDx Hldgs Q1 Earnings May 09, 2023 Via Benzinga Earnings Preview: GeneDx Hldgs May 08, 2023 Via Benzinga GeneDx Announces Data Demonstrating that Whole Exome and Genome Sequencing Report Fewer Variants of Uncertain Significance (VUS) than Multi-Gene Panel Testing Published in Genetics in Medicine August 21, 2023 From GeneDx Holdings Corp. Via GlobeNewswire GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 08, 2023 From GeneDx Holdings Corp. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's After-Market Session August 08, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Friday August 11, 2023 During the Friday's sesion, 157 stocks hit new 52-week lows. Via Benzinga GeneDx Reports Second Quarter 2023 Financial Results and Business Highlights August 08, 2023 From GeneDx Holdings Corp. Via GlobeNewswire PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care August 07, 2023 Study is first of its kind to compare diagnostic rates across short- and long-read sequencing platforms From GeneDx Holdings Corp.; PacBio Via GlobeNewswire GeneDx and Prognos Health Announce Strategic Partnership to Help Rare Disease Patients More Rapidly Gain Access to Potential Treatment Options July 19, 2023 Partnership allows commercial biopharma companies to leverage real-time data within comprehensive Prognos Marketplace to provide available treatment options for patients From GeneDx Holdings Corp. Via GlobeNewswire GeneDx to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023 July 18, 2023 From GeneDx Holdings Corp. Via GlobeNewswire GeneDx to Present New Data on Urine Mitochondrial DNA Testing at the 2023 United Mitochondrial Disease Foundation’s Mitochondrial Medicine Symposium June 28, 2023 From GeneDx Holdings Corp. Via GlobeNewswire GeneDx Announces New Tool to Help Harness Human Pangenome Diversity for Clinical Interpretation of Variants June 26, 2023 From GeneDx Holdings Corp. Via GlobeNewswire GeneDx Commends the States of Arizona and Florida for Adding Rapid Whole Genome Sequencing (rWGS) as a Covered Benefit for Medicaid Pediatric Patients June 20, 2023 Eight state Medicaid programs now cover rWGS in the pediatric inpatient setting, with active bills in other states From GeneDx Holdings Corp. Via GlobeNewswire GeneDx to Participate in Upcoming Investor Conferences in June May 24, 2023 From GeneDx Holdings Corp. Via GlobeNewswire GeneDx to Participate in World Orphan Drug Congress Keynote and Panel Presentations May 23, 2023 Keynote session to highlight value of GeneDx genomic data and clinical insights to accelerate genetic neurodevelopmental disorder pipeline for Mahzi Therapeutics From GeneDx Holdings Corp. Via GlobeNewswire GeneDx Regains Compliance with Nasdaq Minimum Bid Price Requirement May 22, 2023 From GeneDx Holdings Corp. Via GlobeNewswire Stocks That Hit 52-Week Lows On Friday May 12, 2023 On Friday, 199 companies reached new 52-week lows. Via Benzinga GeneDx Reports First Quarter 2023 Financial Results and Business Highlights May 09, 2023 From GeneDx Holdings Corp. Via GlobeNewswire GeneDx Adds Buccal Swab as Non-Invasive Whole Genome Sequencing Sample Collection Option May 04, 2023 New Option Enables Easier DNA Sample Collection from Biological Parents to Aid in Disease Diagnosis From GeneDx Holdings Corp. Via GlobeNewswire Earnings Scheduled For May 9, 2023 May 09, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million. Via Benzinga GeneDx Announces Clarification Regarding CUSIP Number for Public Warrant Holders May 03, 2023 From GeneDx Holdings Corp. Via GlobeNewswire Why GeneDx Holdings Stock Lagged the Market Today April 28, 2023 A financial-engineering move about to be made by the company is an indication of some deep and challenging problems. Via The Motley Fool GeneDx Announces Reverse Stock Split April 28, 2023 From GeneDx Holdings Corp. Via GlobeNewswire GeneDx to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023 April 18, 2023 From GeneDx Holdings Corp. Via GlobeNewswire GeneDx Appoints Devin K. Schaffer, J.D., M.B.A, as General Counsel April 03, 2023 From GeneDx Holdings Corp. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Pre-Market Session March 31, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday March 31, 2023 It's time for another dive into the biggest pre-market stock movers with all the hot topics traders need to know about on Friday! Via InvestorPlace < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.